Many companies have delivered sustained growth by expanding beyond their core business and into adjacent markets. In this eBook, we’ll explore seven key elements of effective adjacency strategies, and share data-driven tips for boosting your success.
This guide explores eight key capabilities in which high-end independent talent are serving life science companies, from market access and clinical solutions to strategy and transformation...
Life science executives are turning to independent talent for real-world experience and strategic rigor in areas like market access, clinical operations, commercial strategy, and digital health.
Following the turbulence of last year, corporate development leaders are now charting a path to renewed growth in 2021 with help from high-end independent talent.
Independent talent provide strategy and ICG leaders with targeted support on everything from strategic plans and implementation roadmaps to harnessing data and identifying promising opportunities.
Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.
Pursuing growth into personalized medicine and safer, more effective drug therapy, an F200 biopharmaceutical company wanted to improve its cross-functional end-to-end control strategy and tactics...
A compilation of thought pieces from BTG talent on strategic planning and execution, focusing priorities, making fast decisions, and adapting strategy as part of a crisis response
Conducting a market analysis doesn’t have to be complex or expensive. But it does have to be expertly done.
Johnson & Johnson procurement head George Post talks about building the company's on-demand talent program, Specialists on Demand. Read or listen.
Daniel Lee, who created Pfizer's Consulting and Execution Group, or PCE, shares best practices for building a successful internal consulting group.
Pfizer executive Tim Hylan speaks to us about why he works with freelance pharma consultants.
Over the past few years, the life science industry has witnessed unprecedented pharma M&A activity. Both 2015 and 2016 saw a wave of consolidation—driven largely by specialty pharma companies,...
Jump-start your next deal with independent M&A consultants and experts from business talent group.
Innovation expert Steve Wunker joins BTG's Leah Hoffmann to discuss how companies can adapt business strategies to the coronavirus (COVID-19) pandemic and all the upheaval that it has brought.
Innovation is typically seen as a way to boost revenues, but it can also be used to cut costs. Expert Stephen Wunker explains.
There's often more focus on the strategic planning process than on actual strategic thought. Create more effective plans with this comprehensive guide.
Statistically speaking, most merger integrations fail—between 70% and 90%, according to McKinsey and Harvard Business Review. What’s worse, those numbers are consistent in study after study… and...
The head of global marketing at a Fortune 100 life science company faced gaps in his team’s capabilities after an enterprise-wide reorganization. As he prepared to re-launch a product within its...
A global life science company needed needed a fresh look at the competitiveness of its US portfolio with respect to current products and the five-year pipeline. Lacking the internal resources to...
An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for...